Arcus Biosciences, Inc. Common Stock (NY:RCUS)

24.30 -0.14 (-0.59%)

Delayed Quote Updated: 10:21 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arcus Biosciences, Inc. Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Arcus Biosciences Announces New Employment Inducement Grants

June 26, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

June 09, 2023

From Arcus Biosciences

Via Business Wire

Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review ↗

June 09, 2023

The Nasdaq held near 52-week highs while small caps ramped up.

Via Investor's Business Daily

Citigroup Maintains Buy Rating for Arcus Biosciences: Here's What You Need To Know ↗

May 26, 2023

Via Benzinga

Earnings Preview For Arcus Biosciences ↗

May 08, 2023

Via Benzinga

Arcus Biosciences Earnings Perspective: Return On Capital Employed ↗

March 06, 2023

Via Benzinga

ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes ↗

June 05, 2023

ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference.

Via Investor's Business Daily

Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study

June 03, 2023

From Gilead Sciences, Inc.

Via Business Wire

3 Undervalued Biotech Stocks to Buy Before They Blast Off ↗

June 02, 2023

Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.

Via InvestorPlace

Arcus Biosciences to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

May 30, 2023

From Arcus Biosciences

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 26, 2023

Via Benzinga

Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 26, 2023

Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.

Via Benzinga

Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday ↗

May 26, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class ↗

May 26, 2023

Roche tested its treatment in patients with liver cancer and found "meaningful" results.

Via Investor's Business Daily

Nasdaq Rises 1%; US Goods Trade Gap Widens In April ↗

May 26, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 1% on Friday. Following the market opening Friday, the Dow traded up 0.87% to 33,050.97 while the NASDAQ rose 1.06% to...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 26, 2023

Via Benzinga

Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

May 26, 2023

Gainers Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 26, 2023

It's time for another dive into the biggest pre-market stock movers as we check out what's happening this morning on Friday!

Via InvestorPlace

Arcus Biosciences Announces New Employment Inducement Grants

May 24, 2023

From Arcus Biosciences

Via Business Wire

3 Analyst Upgrades That Smart Investors Won’t Ignore ↗

May 17, 2023

In many cases, analyst upgrades can point investors to opportunities like the ones in the stocks on this list.

Via InvestorPlace

Presentations at the 2023 ASCO Annual Meeting Highlight Arcus Biosciences’ Expanding Portfolio of Investigational Medicines and Late-Stage Studies Across Multiple Types of Cancer

May 17, 2023

From Arcus Biosciences

Via Business Wire

Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation

May 15, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update

May 09, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

May 08, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

April 25, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

April 11, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

March 09, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences to Participate in the Barclays Global Healthcare Conference

March 02, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update

February 28, 2023

From Arcus Biosciences

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.